• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载多柔比星的自行组装吲哚美辛二聚体纳米粒子用于耐药乳腺癌的联合治疗。

Self-Assembled Indomethacin Dimer Nanoparticles Loaded with Doxorubicin for Combination Therapy in Resistant Breast Cancer.

机构信息

Engineering Research Center for Biomedical Materials, Anhui Key Laboratory of Modern Biomanufacturing, School of Life Sciences , Anhui University , 111 Jiulong Road , Hefei , Anhui Province 230601 , P. R. China.

出版信息

ACS Appl Mater Interfaces. 2019 Aug 14;11(32):28597-28609. doi: 10.1021/acsami.9b05855. Epub 2019 Jul 30.

DOI:10.1021/acsami.9b05855
PMID:31314480
Abstract

An ortho-ester-linked indomethacin (IND) dimer-based nanodrug delivery system was prepared to improve the therapeutic effect of doxorubicin (DOX) by reversing the multidrug resistance. The synthesized dimer (IND-OE) could form stable nanoparticles (IND-OE/DOX) loaded with DOX via the single-emulsion method. Compare to insensitive nanoparticles (IND-C12/DOX), IND-OE/DOX showed a rapid degradation behavior and accelerated drug release at mildly acidic environments. In vitro cell experiments verified that IND-OE nanoparticles could increase DOX concentration due to the efficient intracellular drug release by the degradation of the ortho ester as well as reduced DOX efflux by IND-mediated P-gp downregulation. In vivo studies further demonstrated that IND-OE/DOX displayed the maximized synergetic antitumor efficacy than free DOX or IND-C12/DOX, and the tumor inhibition rates versus saline were 46.78% (free DOX), 60.23% (IND-C12/DOX), and 80.62% (IND-OE/DOX). Overall, this strategy of combination with chemosensitizers and ortho ester linkage has great potential to serve as an amplifying chemotherapy platform against various drug-resistant tumors.

摘要

一种基于正交酯键连接的吲哚美辛(IND)二聚体的纳米药物递送系统被制备出来,以通过逆转多药耐药性来提高阿霉素(DOX)的治疗效果。合成的二聚体(IND-OE)可以通过单乳液法形成稳定的载有 DOX 的纳米颗粒(IND-OE/DOX)。与不敏感的纳米颗粒(IND-C12/DOX)相比,IND-OE/DOX 在轻度酸性环境下表现出快速降解行为和加速药物释放。体外细胞实验验证,IND-OE 纳米颗粒可以通过正交酯的降解增加 DOX 浓度,以及通过 IND 介导的 P-糖蛋白下调减少 DOX 外排,从而实现有效的细胞内药物释放。体内研究进一步表明,与游离 DOX 或 IND-C12/DOX 相比,IND-OE/DOX 显示出最大化的协同抗肿瘤疗效,并且与生理盐水相比,肿瘤抑制率分别为 46.78%(游离 DOX)、60.23%(IND-C12/DOX)和 80.62%(IND-OE/DOX)。总的来说,这种与化疗增敏剂和正交酯键结合的策略具有作为针对各种耐药肿瘤的放大化疗平台的巨大潜力。

相似文献

1
Self-Assembled Indomethacin Dimer Nanoparticles Loaded with Doxorubicin for Combination Therapy in Resistant Breast Cancer.载多柔比星的自行组装吲哚美辛二聚体纳米粒子用于耐药乳腺癌的联合治疗。
ACS Appl Mater Interfaces. 2019 Aug 14;11(32):28597-28609. doi: 10.1021/acsami.9b05855. Epub 2019 Jul 30.
2
Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.通过与聚酰胺-胺树枝状聚合物共价结合来共递送顺铂和阿霉素,以增强协同癌症治疗。
Acta Biomater. 2019 Jan 15;84:367-377. doi: 10.1016/j.actbio.2018.12.007. Epub 2018 Dec 5.
3
Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.基于葡聚糖和吲哚美辛的载阿霉素氧化还原响应性胶束用于耐药性乳腺癌
Int J Nanomedicine. 2017 Aug 22;12:6153-6168. doi: 10.2147/IJN.S141229. eCollection 2017.
4
Indomethacin-grafted and pH-sensitive dextran micelles for overcoming inflammation-mediated multidrug resistance in breast cancer.载吲哚美辛和 pH 敏感的葡聚糖胶束克服炎症介导的乳腺癌多药耐药。
Carbohydr Polym. 2020 Jun 1;237:116139. doi: 10.1016/j.carbpol.2020.116139. Epub 2020 Mar 7.
5
A small molecule nanodrug consisting of pH-sensitive ortho ester-dasatinib conjugate for cancer therapy.一种由 pH 敏感邻酯-达沙替尼偶联物组成的小分子纳米药物,用于癌症治疗。
Eur J Pharm Biopharm. 2021 Jun;163:188-197. doi: 10.1016/j.ejpb.2021.04.008. Epub 2021 Apr 14.
6
A novel injectable phospholipid gel co-loaded with doxorubicin and bromotetrandrine for resistant breast cancer treatment by intratumoral injection.一种新型可注射磷脂凝胶,共负载阿霉素和溴粉防己碱,用于通过瘤内注射治疗耐药性乳腺癌。
Colloids Surf B Biointerfaces. 2016 Apr 1;140:538-547. doi: 10.1016/j.colsurfb.2015.11.029. Epub 2015 Nov 17.
7
Co-delivery of Poria cocos extract and doxorubicin as an 'all-in-one' nanocarrier to combat breast cancer multidrug resistance during chemotherapy.作为一种“一体化”纳米载体,共递送茯苓提取物和阿霉素用于化疗期间治疗乳腺癌多药耐药性。
Nanomedicine. 2020 Jan;23:102095. doi: 10.1016/j.nano.2019.102095. Epub 2019 Oct 25.
8
Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer.通过 pH 敏感型纳米粒共递送 DOX 和 PDTC 以克服乳腺癌的多药耐药性。
Colloids Surf B Biointerfaces. 2019 Sep 1;181:185-197. doi: 10.1016/j.colsurfb.2019.05.042. Epub 2019 May 20.
9
Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.可还原交联透明质酸纳米粒用于主动靶向和智能递药系统对耐药 CD44+人乳腺癌肿瘤异种移植瘤的治疗。
J Control Release. 2015 May 10;205:144-54. doi: 10.1016/j.jconrel.2015.01.012. Epub 2015 Jan 14.
10
Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.通过核壳-冠纳米粒子实现阿霉素和双硫仑的细胞内共递药以实现协同的乳腺癌细胞杀伤作用。
Biomater Sci. 2018 Jun 25;6(7):1869-1881. doi: 10.1039/c8bm00271a.

引用本文的文献

1
Drug self-delivery systems: A comprehensive review on small molecule nanodrugs.药物自递送系统:小分子纳米药物综述
Bioimpacts. 2024 Oct 27;15:30161. doi: 10.34172/bi.30161. eCollection 2025.
2
NIR-IIb fluorescence antiangiogenesis copper nano-reaper for enhanced synergistic cancer therapy.用于增强协同癌症治疗的近红外二区荧光抗血管生成铜纳米收割机
J Nanobiotechnology. 2024 Feb 19;22(1):73. doi: 10.1186/s12951-024-02343-5.
3
Stimulus-responsive self-assembled prodrugs in cancer therapy.刺激响应性自组装前药在癌症治疗中的应用
Chem Sci. 2022 Mar 18;13(15):4239-4269. doi: 10.1039/d2sc01003h. eCollection 2022 Apr 13.
4
Targeted Cancer Therapy via pH-Functionalized Nanoparticles: A Scoping Review of Methods and Outcomes.通过pH功能化纳米颗粒进行的靶向癌症治疗:方法与结果的范围综述
Gels. 2022 Apr 11;8(4):232. doi: 10.3390/gels8040232.
5
Recent Advances in Paclitaxel-based Self-Delivery Nanomedicine for Cancer Therapy.紫杉醇基自递药纳米医学在癌症治疗中的最新进展。
Curr Med Chem. 2021;28(31):6358-6374. doi: 10.2174/0929867327666201111143725.